Tudor Investment Corp
CLSD

Tudor Investment Corp’s Clearside Biomedical CLSD Stock Holding History

Tudor Investment Corp’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,417
Closed -$228K – 1064
2018
Q1 		$228K Buy
+1,417
New +$173K 0.01% 828
2017
Q1 		– Sell
-8,829
Closed -$1.18M – 1390
2016
Q4 		$1.18M Buy
+8,829
New +$2.22M 0.03% 303

Other funds holding CLSD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Tudor Investment Corp's CLSD Position: Q2 2018 in Review

Tudor Investment Corp sold out of Clearside Biomedical (CLSD) in Q2 2018, closing a stake of 1,417 shares — an estimated $228K sold.

Tudor Investment Corp first reported a position in CLSD in Q4 2016 and held it in 2 quarters. The position peaked at $1.18M in Q4 2016. 86 funds tracked by Wall St. Rank hold CLSD as of Q2 2018.

  • Tudor Investment Corp reported no remaining Clearside Biomedical position as of Q2 2018 after selling out during the quarter.
  • Tudor Investment Corp sold 1,417 Clearside Biomedical shares in Q2 2018, an estimated $228K.
  • Tudor Investment Corp first reported a position in Clearside Biomedical in Q4 2016 and held it in 2 quarters.
  • Tudor Investment Corp's Clearside Biomedical position peaked at $1.18M in Q4 2016.
  • 86 funds tracked by Wall St. Rank held Clearside Biomedical as of Q2 2018.

Based on Tudor Investment Corp's 13F filing for Q2 2018, filed 14 Aug 2018.